
Bioorganic and Medicinal Chemistry Letters p. 1831 - 1836 (1999)
Update date:2022-08-04
Topics:
Kozikowski, Alan P.
Simoni, Daniele
Roberti, Marinella
Rondanin, Riccardo
Wang, Shaomeng
Du, Pingfeng
Johnson, Kenneth M.
In order to further explore the importance of cocaine's bridge nitrogen atom in binding to the dopamine transporter (DAT), we have synthesized the previously known racemic 8-oxa-norcocaines 3-6 in which the nitrogen atom has been replaced by oxygen. Additionally, to avoid incorrect interpretations of biological data that may stem from the use of racemic materials, several of these analogues were synthesized and tested in non-racemic form. (-)-8-Oxa- norcocaine (3) was found to bind to the cocaine recognition site and to inhibit the dopamine transporter with potencies only about 8-fold and 4- fold, respectively, less than those of norcocaine (2). (-)-8-Oxa- pseudonorcocaine (4) as well as (+)-8-oxa-norcocaine (3) were found to be comparable in activity to (-)-oxa-norcocaine. These pharmacological findings support our earlier suggestion that cocaine is likely to bind in its neutral form to the DAT.
View MoreWUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Anhui Xinyuan Technology Co.,Ltd
Contact:0086-559-3515800
Address:No.16 Zijin Rd, Circular Economic Zone, Huizhou District, Huangshan Anhui China
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
website:http://www.ringchemicals.com/
Contact:+1-416-493-6870
Address:Toronto, Canada
website:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Doi:10.1021/acs.joc.9b01669
(2019)Doi:10.1039/c4cc01327a
(2014)Doi:10.1002/hlca.19400230122
(1940)Doi:10.1021/ja00175a051
(1990)Doi:10.1515/znb-2010-1214
(2010)Doi:10.1039/c0cc05125j
(2011)